<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The radiation response of Epstein-Barr virus (EBV)-immortalised lymphoblastoid cell lines derive from <z:e sem="disease" ids="C0085390" disease_type="Neoplastic Process" abbrv="LFS">Li-Fraumeni syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e>) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e>-like individuals was investigated </plain></SENT>
<SENT sid="1" pm="."><plain>Cells from <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e>-like cases showed an accumulation of p53 protein following 137Cs gamma-irradiation, which was associated with cell cycle arrest at the G1/S border </plain></SENT>
<SENT sid="2" pm="."><plain>This response was indistinguishable from that seen in cells derived from <z:mpath ids='MPATH_458'>normal</z:mpath> individuals, and occurred in cases with missense mutations in the TP53 gene at codons 175, 180, 220 and 248 and also in two <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e>-like individuals with no TP53 mutation </plain></SENT>
<SENT sid="3" pm="."><plain>Previous studies using lymphocytes and fibroblasts from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e> individuals have demonstrated abnormal radiation responses in these cells </plain></SENT>
<SENT sid="4" pm="."><plain>This suggest cell type specificity in the contribution of a mutant p53 protein to phenotype </plain></SENT>
</text></document>